Skip to main content

Most Popular in News

Most Recent

U.S. map with graphs and charts: Teen mental health statistics

Teen mental health statistics 2025

Teen mental health is a growing concern. Learn about common conditions like anxiety and depression, key statistics, risk factors, and ways to support teens.
Clipboard with graphs: Clomid statistics

Clomid statistics and success rate

Learn how Clomid (clomiphene citrate) helps with infertility. Explore statistics on its effectiveness, usage rates, costs, side effects, and success stories from fertility experts.
FDA stamp - Saxenda generic FDA approval

FDA approves generic Saxenda

Liraglutide is the first generic GLP-1 specifically for weight loss in the U.S.
An FDA approval stamp for the expansion of Wegovy to treat liver disease

FDA approves Wegovy for MASH

In a historic first, this medication gains an expanded role in reversing liver fibrosis beyond its known weight and heart benefits
Clipboard with charts and graphs: Nicotine statistics and facts

Nicotine statistics and facts 2025

What is nicotine, and how harmful is it? Discover its health effects, cost, addiction potential, rising vape use, and efforts to reduce tobacco-related disease and death.
Clipboard with charts and graphs: Low testosterone facts and statistics

Low testosterone facts and statistics

Testosterone replacement therapy is on the rise. Discover key stats, pricing, usage trends, and medical insights on how TRT treats low testosterone in men.
Map of the U.S. with smart phones displaying charts: Linzess statistics

Linzess statistics and facts

Explore how Linzess treats IBS and chronic constipation, including usage stats, cost, effectiveness, insurance coverage, and potential side effects.
Bar chart on a clipboard: Vitamin D facts and statistics

Vitamin D facts and statistics

Wondering if you’re getting enough vitamin D? Discover deficiency symptoms, who’s most at risk, the benefits of supplements, and how much is too much.
Three mobile devices with charts on their displays and a map of the U.S. behind them: Mounjaro statistics

Mounjaro statistics 2025

Mounjaro use grew by more than 250% each month in its first year of release
Three mobile devices with charts on them and a map of the U.S. behind them: Wegovy facts and statistics

Wegovy facts and statistics 2025

These current stats illustrate the popularity and effectiveness of Wegovy (semaglutide)
Three mobile devices with charts on them: Opioid statistics

Opioid statistics, 2025

Facts and figures that illustrate the impact of opioid misuse
FDA approval stamp | Widaplik for hypertension

Widaplik for hypertension

It’s a new triple combination medication to treat high blood pressure
A tablet with charts on it: Statin statistics

Statin statistics 2025

How many people are taking statins, how much we spend on these cholesterol-lowering drugs, and more
A tablet with charts on it: Insulin statistics

Insulin statistics 2025

How many people rely on insulin around the world, how insulin prices have changed, and more
Three mobile devices with charts on them: Fentanyl facts and statistics

Fentanyl facts and statistics

Current fentanyl stats, overdose facts, and why it’s so dangerous when misused
A chart on a clipboard: Ozempic statistics

Ozempic statistics 2025

How many people are using Ozempic in 2025?
FDA approves generic Xarelto

FDA approves generic Xarelto

There’s a new—hopefully, lower cost—option for people who take anticoagulants to manage heart disease
FDA stamp - Merilog

FDA approves rapid-acting insulin biosimilar

Merilog works like NovoLog to help control blood sugar when injected five to ten minutes before meals
An FDA approval stamp for the approval of Ozempic and kidney function

Ozempic for kidney disease

This diabetes medication is now indicated to prevent the worsening of kidney disease, kidney failure, and death due to cardiovascular disease
victoza generic - FDA approval

FDA approves first generic once-daily GLP-1

Liraglutide, the generic of Victoza, is now available to treat Type 2 diabetes, alongside diet and exercise
Zepbound obstructive sleep apnea - FDA stamp

Zepbound for sleep apnea

It’s the first medication that reduces symptom severity, reducing breathing interruptions at night
FDA stamp - FDA warning compounded semaglutide

FDA issues warning to GLP-1 compounders

The U.S. Food and Drug Administration is sounding the alarm about the risks of taking unapproved versions of Ozempic, Wegovy, Zepbound, and Mounjaro
Neffy - FDA approval

FDA approves epinephrine nasal spray

Neffy is the first needle-free epinephrine to treat life-threatening anaphylaxis
Pivya FDA approval

New Rx approved for simple UTIs

Adult women now have another antibiotic option for this common condition
A stamp for FDA approval - naloxone OTC

Wegovy use expanded by FDA

This expanded approval provides a new indication for the popular weight loss medication
Jubbonti-Wyost - FDA approval

Prolia biosimilar approved

These biologic alternatives signal more affordable options for the pricey injectable medications
Clipboard with charts: Lung cancer statistics

Lung cancer statistics 2025

Each year, 230,000 new cases of lung cancer are diagnosed. Get updated lung cancer statistics here.
FDA approval stamp

FDA approves first OTC CGM

The device can help people with and without diabetes monitor their blood glucose levels
FDA approval - fezolinetant

New food allergy med

Previously approved for allergic asthma, this injectable medication can help people with severe reactions
A stamp for FDA approval - naloxone OTC

Canada Rx import approved by FDA

A landmark decision granted the state the authority to obtain these prescriptions to help stem rising costs
1 2 3 7